Search

Jia-hai Lee

Examiner (ID: 11915)

Most Active Art Unit
1658
Art Unit(s)
1658, 1676
Total Applications
597
Issued Applications
248
Pending Applications
119
Abandoned Applications
241

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14158707 [patent_doc_number] => 20190106456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/212500 [patent_app_country] => US [patent_app_date] => 2018-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212500 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/212500
COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME Dec 5, 2018 Abandoned
Array ( [id] => 14338863 [patent_doc_number] => 20190151404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEEASE [patent_app_type] => utility [patent_app_number] => 16/205112 [patent_app_country] => US [patent_app_date] => 2018-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16205112 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/205112
THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEEASE Nov 28, 2018 Abandoned
Array ( [id] => 14342157 [patent_doc_number] => 20190153051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => FUSION PROTEIN OF C2 DOMAIN AND AKT KINASE DOMAIN FRAGMENT AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/198088 [patent_app_country] => US [patent_app_date] => 2018-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198088 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/198088
FUSION PROTEIN OF C2 DOMAIN AND AKT KINASE DOMAIN FRAGMENT AND USE THEREOF Nov 20, 2018 Abandoned
Array ( [id] => 14277859 [patent_doc_number] => 20190136214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => GENERATION OF STABLE PROTEIN FILMS USING FLUOROUS SOLVENT [patent_app_type] => utility [patent_app_number] => 16/180260 [patent_app_country] => US [patent_app_date] => 2018-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8000 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180260 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/180260
Generation of stable protein films using fluorous solvent Nov 4, 2018 Issued
Array ( [id] => 15381851 [patent_doc_number] => 10532084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Chondrocyte extracellular matrix-derived peptide [patent_app_type] => utility [patent_app_number] => 16/178618 [patent_app_country] => US [patent_app_date] => 2018-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 8434 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178618 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/178618
Chondrocyte extracellular matrix-derived peptide Nov 1, 2018 Issued
Array ( [id] => 15395829 [patent_doc_number] => 10538558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Inhibition of TCR signaling with peptide variants [patent_app_type] => utility [patent_app_number] => 16/166984 [patent_app_country] => US [patent_app_date] => 2018-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29322 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166984 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/166984
Inhibition of TCR signaling with peptide variants Oct 21, 2018 Issued
Array ( [id] => 13982637 [patent_doc_number] => 20190060476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS [patent_app_type] => utility [patent_app_number] => 16/161441 [patent_app_country] => US [patent_app_date] => 2018-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16161441 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/161441
CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS Oct 15, 2018 Abandoned
Array ( [id] => 16252169 [patent_doc_number] => 20200261543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => COMBINATION THERAPY FOR TREATMENT OF BONE DISORDERS [patent_app_type] => utility [patent_app_number] => 16/754944 [patent_app_country] => US [patent_app_date] => 2018-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11262 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754944 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754944
COMBINATION THERAPY FOR TREATMENT OF BONE DISORDERS Oct 10, 2018 Abandoned
Array ( [id] => 14649455 [patent_doc_number] => 20190231856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING INTRACEREBRAL HEMORRHAGE [patent_app_type] => utility [patent_app_number] => 16/157194 [patent_app_country] => US [patent_app_date] => 2018-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157194 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/157194
COMPOSITIONS AND METHODS FOR TREATING INTRACEREBRAL HEMORRHAGE Oct 10, 2018 Abandoned
Array ( [id] => 14227639 [patent_doc_number] => 20190125992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-02 [patent_title] => INTRANASAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 16/142646 [patent_app_country] => US [patent_app_date] => 2018-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142646 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/142646
INTRANASAL ADMINISTRATION Sep 25, 2018 Abandoned
Array ( [id] => 15604307 [patent_doc_number] => 10583194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-10 [patent_title] => Minimally toxic prodrugs [patent_app_type] => utility [patent_app_number] => 16/133684 [patent_app_country] => US [patent_app_date] => 2018-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26438 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133684 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133684
Minimally toxic prodrugs Sep 16, 2018 Issued
Array ( [id] => 17133695 [patent_doc_number] => 11135230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Lipid compositions with high DHA content [patent_app_type] => utility [patent_app_number] => 16/133185 [patent_app_country] => US [patent_app_date] => 2018-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 18163 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133185 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133185
Lipid compositions with high DHA content Sep 16, 2018 Issued
Array ( [id] => 15280091 [patent_doc_number] => 10512695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Fast dissolving pharmaceutical composition [patent_app_type] => utility [patent_app_number] => 16/115650 [patent_app_country] => US [patent_app_date] => 2018-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7790 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115650 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/115650
Fast dissolving pharmaceutical composition Aug 28, 2018 Issued
Array ( [id] => 16598062 [patent_doc_number] => 20210024593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => MODIFIED HEAT SHOCK PROTEINS [patent_app_type] => utility [patent_app_number] => 16/641013 [patent_app_country] => US [patent_app_date] => 2018-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641013 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/641013
MODIFIED HEAT SHOCK PROTEINS Aug 23, 2018 Abandoned
Array ( [id] => 15990583 [patent_doc_number] => 20200171162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => E-POLY-L-LYSINE DERIVATIVES HAVING FUNCTIONAL GROUP FOR CLICK CHEMISTRY, METHOD FOR PRODUCING THE SAME, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/640468 [patent_app_country] => US [patent_app_date] => 2018-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/640468
E-POLY-L-LYSINE DERIVATIVES HAVING FUNCTIONAL GROUP FOR CLICK CHEMISTRY, METHOD FOR PRODUCING THE SAME, AND USE THEREOF Aug 22, 2018 Abandoned
Array ( [id] => 14069501 [patent_doc_number] => 20190083638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => NICLOSAMIDE-CONJUGATED POLYPEPTIDE NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 16/045556 [patent_app_country] => US [patent_app_date] => 2018-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045556 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/045556
NICLOSAMIDE-CONJUGATED POLYPEPTIDE NANOPARTICLES Jul 24, 2018 Abandoned
Array ( [id] => 16807855 [patent_doc_number] => 20210130408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => COMPOUND AND METHOD FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 16/633701 [patent_app_country] => US [patent_app_date] => 2018-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9189 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633701 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/633701
COMPOUND AND METHOD FOR PRODUCING THE SAME Jul 23, 2018 Pending
Array ( [id] => 18412106 [patent_doc_number] => 11666633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Long-acting peptide analogs [patent_app_type] => utility [patent_app_number] => 16/043642 [patent_app_country] => US [patent_app_date] => 2018-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 6240 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16043642 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/043642
Long-acting peptide analogs Jul 23, 2018 Issued
Array ( [id] => 15862997 [patent_doc_number] => 20200138902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => CLUSTERIN FOR USE IN THE TREATMENT OF THROMBOTIC MICROANGIOPATHIES [patent_app_type] => utility [patent_app_number] => 16/632684 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6217 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632684 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/632684
Clusterin for use in the treatment of thrombotic microangiopathies Jul 19, 2018 Issued
Array ( [id] => 13549067 [patent_doc_number] => 20180326081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => MACROMOLECULES [patent_app_type] => utility [patent_app_number] => 16/039997 [patent_app_country] => US [patent_app_date] => 2018-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039997 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/039997
MACROMOLECULES Jul 18, 2018 Abandoned
Menu